Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.
Giacomo MontagnaMonica MorrowPublished in: Expert review of anticancer therapy (2020)
Introduction: The contralateral prophylactic mastectomy (CPM) rate in the U.S. has been steadily increasing. This is of particular concern because many women who undergo this procedure are candidates for breast-conserving surgery.Areas covered: CPM's medical benefit is related to the risk of contralateral cancer development and whether CPM provides a survival benefit. Contralateral cancer rates have decreased, and CPM does not provide a survival benefit. Other potential benefits of the procedure may be improved quality of life; these data are reviewed. Research efforts have been undertaken to better understand the decision-making process of patients who consider, and ultimately undergo, this procedure.Expert opinion: Decisional traits, personal values, the desire for peace of mind, and the desire to obtain breast symmetry are important factors that drive a woman's decision to undergo CPM. Additionally, many patients lack the knowledge on how different types of breast surgery impact outcomes. To improve the shared decision-making process, a stepwise approach to address possible misconceptions, and clarify the real risks/benefits of this procedure should be utilized. A clear recommendation (for/against) should be made for every patient with newly diagnosed breast cancer who considers CPM. Communication tools to assist patients and surgeons in this process are sorely needed.
Keyphrases
- newly diagnosed
- end stage renal disease
- minimally invasive
- ejection fraction
- healthcare
- decision making
- prognostic factors
- peritoneal dialysis
- type diabetes
- coronary artery disease
- machine learning
- risk assessment
- skeletal muscle
- papillary thyroid
- dna methylation
- young adults
- big data
- genome wide
- artificial intelligence
- climate change
- rectal cancer
- breast cancer risk
- percutaneous coronary intervention